AnalystsDaniel StauderDaniel Stauder's Stock Forecasts
AnalystsDaniel Stauder
Analyst Ranking
Top 25%
#1207 out of 4995 analysts
Average Return
+21.94%
Win Rate
76%13 out of 17
Risk vs Reward
Poor
Good
Daniel Stauder's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Lemaitre Vascular IncLMAT | +80.09% | $48.46 | $87.27 | 2023-10-23 - 2024-10-22 | Buy |
Artivion IncAORT | +75.39% | $25.56 | $44.83 | 2025-02-25 - 2025-08-22 | Buy |
Artivion IncAORT | +66.90% | $26.86 | $44.83 | 2024-10-23 - 2025-08-22 | Buy |
Artivion IncAORT | +63.49% | $27.42 | $44.83 | 2025-05-06 - 2025-08-22 | Buy |
Artivion IncAORT | +50.28% | $29.83 | $44.83 | 2024-12-10 - 2025-08-22 | Buy |
Daniel Stauder Analyst Color
Get additional color on Daniel Stauder's coverage of popular stocks
Daniel Stauder's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Artivion IncAORT | 5 | Buy | $42.00 | -6.31% | Maintains | 17 days ago |
Atricure IncATRC | 6 | Buy | $60.00 | +59.32% | Reiterates | 4 months ago |
Neuronetics IncSTIM | 1 | Buy | $7.00 | +105.88% | Maintains | 6 months ago |
Lemaitre Vascular IncLMAT | 4 | Strong Buy | $110.00 | +9.64% | Maintains | 6 months ago |
Axon Enterprise IncAXON | 1 | Buy | $725.00 | -5.38% | Reiterates | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.